Scaling Manufacturing, Not Facilities: Demonstrating the potential of a microfluidic-powered Cell Factory to make CAR-T better, faster, cheaper!
- Introduce Astraveus and the Lakhesys Cell Factory to the US cell therapy community
- Demonstrate a novel all-in-one CAR-T process development and manufacturing approach based on microfluidic technology
- Deliver scientific proof points to enable orderof-magnitude improvements in manufacturing cost, patient access and CapEx investment related to cell therapies
- Engage with new partners for user-testing collaborations of the LakhesysTM system